Estados financieros detallados de Praxis Precision Medicines, Inc. (PRAX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | $2.4M | $8.6M | 0 |
| Coste de Ventas | $1000 | $679000 | 0 | 0 | $154.4M | $86.8M | $152.4M | $140000 |
| Beneficio Bruto | -$1000 | -$679000 | 0 | 0 | -$154.4M | -$84.3M | -$143.9M | -$140000 |
| I+D | $18.8M | $29.6M | $45.0M | $120.3M | $155.0M | $86.8M | $152.4M | $267.1M |
| Generales y Administrativos | $3.9M | $6.2M | $17.0M | $47.1M | $59.5M | $42.1M | $56.3M | $59.1M |
| Gastos Operativos | $22.7M | $35.8M | $62.0M | $167.3M | $60.5M | $42.1M | $56.3M | $326.1M |
| Beneficio Operativo | -$22.7M | -$35.8M | -$62.0M | -$167.3M | -$215.0M | -$126.4M | -$200.2M | -$326.2M |
| EBITDA | -$26.3M | -$34.9M | -$61.9M | -$166.9M | -$213.6M | -$122.8M | -$182.5M | -$303.1M |
| Gastos por Intereses | $127000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$26.4M | -$35.6M | -$61.8M | -$167.1M | -$214.0M | -$123.3M | -$182.8M | -$303.3M |
| Impuestos | $133000 | -$84000 | -$8000 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$26.5M | -$35.5M | -$61.8M | -$167.1M | -$214.0M | -$123.3M | -$182.8M | -$303.3M |
| BPA | $-306.73 | $-348.24 | $-103.61 | $-58.96 | $-69.33 | $-18.69 | $-10.21 | $-13.48 |
| BPA Diluido | $-306.73 | $-348.24 | $-103.61 | $-58.96 | $-69.33 | $-18.69 | $-10.21 | $-13.48 |
| Acciones en Circulación (Diluidas) | $86509 | $101975 | $596677 | $2.8M | $3.1M | $6.6M | $17.9M | $22.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$65.8M | -$77.5M | -$39000 | 0 |
| Beneficio Operativo | -$78.4M | -$97.0M | -$105.9M | -$96.9M |
| EBITDA | -$73.9M | -$88.9M | -$92.5M | -$83.7M |
| Beneficio Neto | -$73.9M | -$88.9M | -$92.6M | -$83.7M |
| BPA | $-3.36 | $-3.52 | $-3.20 | $-2.87 |
| BPA Diluido | $-3.36 | $-3.50 | $-3.20 | $-2.87 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $17.9M | $44.8M | $296.6M | $138.7M | $61.6M | $81.3M | $215.4M | $357.3M |
| Inversiones a Corto | 0 | 0 | 0 | $137.2M | $38.9M | 0 | $177.2M | $242.0M |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $19.1M | $45.5M | $302.3M | $287.4M | $110.8M | $84.9M | $404.4M | $610.9M |
| Inmovilizado Material | $103000 | $1.6M | $836000 | $4.9M | $3.9M | $2.7M | $1.4M | $239000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $19.8M | $47.7M | $303.2M | $292.7M | $115.1M | $87.9M | $483.1M | $937.9M |
| Cuentas por Pagar | $3.4M | $2.7M | $4.1M | $10.8M | $14.7M | $5.8M | $12.5M | $24.6M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $5.1M | $6.8M | $15.7M | $38.4M | $34.3M | $15.7M | $37.5M | $59.8M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $5.1M | $7.6M | $15.7M | $41.9M | $39.0M | $18.3M | $37.7M | $59.8M |
| Reservas | -$41.4M | -$81.0M | -$149.6M | -$316.6M | -$530.6M | -$653.9M | -$836.7M | -$1.14B |
| Patrimonio Neto | $14.7M | $40.1M | $287.5M | $250.8M | $76.1M | $69.7M | $445.4M | $878.1M |
| Deuda Total | 0 | $1.5M | $763000 | $4.3M | $3.5M | $2.5M | $1.4M | $110000 |
| Deuda Neta | -$17.9M | -$43.4M | -$295.8M | -$271.6M | -$97.0M | -$78.8M | -$391.2M | -$599.2M |
| Capital Circulante | $14.0M | $38.7M | $286.6M | $249.0M | $76.5M | $69.1M | $366.8M | $551.1M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $149.5M | $357.3M | $536.3M | $474.8M |
| Activos Totales | $396.4M | $937.9M | $1.46B | $1.39B |
| Pasivos Totales | $52.9M | $59.8M | $50.2M | $49.1M |
| Patrimonio Neto | $343.5M | $878.1M | $1.41B | $1.34B |
| Deuda Total | $436000 | $110000 | $1.4M | $1.1M |
Flujo de Caja (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$26.5M | -$35.5M | -$61.8M | -$167.1M | -$214.0M | -$123.3M | -$182.8M | -$303.3M |
| Amortizaciones | $1000 | $679000 | $50000 | $182000 | $419000 | $432000 | $358000 | -$3.5M |
| Compensación en Acciones | $579000 | 0 | $5.2M | $22.7M | $28.6M | $24.9M | $41.4M | $33.9M |
| Cambio en Capital Circulante | $1.5M | $1.4M | $3.2M | $16.1M | -$1.8M | -$13.0M | $10.9M | $22.7M |
| Flujo de Caja Operativo | -$20.7M | -$32.8M | -$52.6M | -$124.6M | -$185.0M | -$111.1M | -$131.8M | -$249.1M |
| Inversiones (CapEx) | -$63000 | -$103000 | 0 | -$1.1M | -$444000 | -$50000 | 0 | -$56000 |
| Adquisiciones | 0 | 0 | 0 | $139.5M | -$97.3M | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$30.0M | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$20.8M | -$32.9M | -$52.6M | -$125.6M | -$185.5M | -$111.2M | -$131.8M | -$249.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$64.7M | -$77.3M | -$86.1M | -$77.6M |
| Inversiones (CapEx) | 0 | 0 | -$62000 | -$245000 |
| Flujo de Caja Libre | -$64.7M | -$77.3M | -$86.1M | -$77.9M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $7.4M | 0 | 0 | $11.3M |
Crecimiento y Márgenes (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | | | +249.5% | -100.0% |
| Crecimiento Beneficio Neto (anual) | | -33.8% | -74.1% | -170.2% | -28.1% | +42.4% | -48.3% | -65.9% |
| Crecimiento BPA (anual) | | -13.5% | +70.2% | +43.1% | -17.6% | +73.0% | +45.4% | -32.0% |
| Cambio en Acciones (anual) | | +17.9% | +485.1% | +374.3% | +8.6% | +114.6% | +171.5% | +25.7% |
| Crecimiento FCF (anual) | | -58.2% | -60.0% | -138.7% | -47.7% | +40.1% | -18.5% | -89.1% |
| Margen Bruto | | | | | | -3445.8% | -1682.0% | |
| Margen Operativo | | | | | | -5164.4% | -2340.3% | |
| Margen EBITDA | | | | | | -5020.2% | -2133.3% | |
| Margen Neto | | | | | | -5037.9% | -2137.5% | |
| Margen FCF | | | | | | -4543.8% | -1540.5% | |
| Tasa Impositiva Efectiva | -0.5% | 0.2% | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-240.25 | $-322.53 | $-88.19 | $-44.38 | $-60.36 | $-16.86 | $-7.36 | $-11.07 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $86509 | $101975 | $596677 | $2.8M | $3.1M | $6.6M | $17.9M | $22.5M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 15.73 |
Ratios Clave (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -1.36 | -1.20 | -7.97 | -5.01 | -0.51 | -1.19 | -7.54 | -21.86 |
| P/VC | 2.46 | 1.06 | 1.71 | 3.33 | 1.44 | 2.11 | 3.09 | 7.55 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 60.04 | 161.13 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -3445.8% | -1682.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -5164.4% | -2340.3% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -5037.9% | -2137.5% | 0.0% |